This document discusses banning probabilistic sensitivity analysis (PSA) and promoting old-fashioned sensitivity analysis (OFSA) in health technology assessments. It argues that PSA should not be the base case analysis because characterizing uncertainty is important, and OFSA provides useful information to policymakers. Interviews with policymakers found that OFSA focuses discussions on important factors and is easier to understand than cost-effectiveness acceptability curves from PSA. The conclusion is that both probabilistic analysis and OFSA have value, but PSA should not be required as the base case.